Literature DB >> 19760425

[Histomorphology of interstitial lung disease and pulmonary vasculitis].

I Bittmann1, K Holl-Ulrich.   

Abstract

Rheumatic diseases or collagen vascular diseases represent a heterogeneous group of immunologically mediated inflammatory disorders. The respiratory system is often affected,the causes being manifold: infection, medication toxicity and specific manifestations of immunological processes due to the underlying disease. The lung can be involved in all its components. Due to their extremely broad differential diagnosis, pulmonary vasculitic syndromes still constitute a major challenge for the pathologist. Pulmonary involvement is frequent in primary systemic vasculitis (PSV) associated with anti-neutrophil-cytoplasmic antibodies (ANCA); other PSV only rarely affect the lungs. Histomorphologically, small vessel vasculitis with neutrophil alveolitis and diffuse alveolar hemorrhage, as well as extravascular intraparenchymal or peribronchial granulomas, can point to PSV. A single biopsy is often insufficient to identify all diagnostic criteria. Therefore, the selection of suitable biopsy material and correlation with clinical, serological and radiological parameters is indispensable. Almost all forms of interstitial lung disease may be present in collagen vascular disease; however, several parallel morphological types, rather than one in isolation, are frequently found.

Entities:  

Mesh:

Year:  2009        PMID: 19760425     DOI: 10.1007/s00393-009-0481-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  26 in total

Review 1.  [Lung and autoimmune diseases--clinical aspects and diagnosis].

Authors:  H-P Hauber; P Zabel
Journal:  Dtsch Med Wochenschr       Date:  2007-08       Impact factor: 0.628

Review 2.  Pulmonary pathology in patients with systemic autoimmune diseases.

Authors:  T V Colby
Journal:  Clin Chest Med       Date:  1998-12       Impact factor: 2.878

Review 3.  Pulmonary involvement in the collagen vascular diseases.

Authors:  G W Hunninghake; A S Fauci
Journal:  Am Rev Respir Dis       Date:  1979-03

Review 4.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

5.  Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis.

Authors:  R A Matthay; M I Schwarz; T L Petty; R E Stanford; R C Gupta; S A Sahn; J C Steigerwald
Journal:  Medicine (Baltimore)       Date:  1975-09       Impact factor: 1.889

6.  Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.

Authors:  Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2005-02-15

7.  The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia.

Authors:  Dong Soon Kim; Bin Yoo; Jin Sung Lee; Eun Kyung Kim; Chae Man Lim; Sang Do Lee; Younsuck Koh; Woo Sung Kim; Won Dong Kim; Thomas V Colby; Masanori Kitiaichi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2002-06       Impact factor: 0.670

8.  Lung biopsy in rheumatoid arthritis.

Authors:  S A Yousem; T V Colby; C B Carrington
Journal:  Am Rev Respir Dis       Date:  1985-05

Review 9.  Chronological evaluation of the onset of histologically confirmed interstitial pneumonia associated with polymyositis/dermatomyositis.

Authors:  Yu Yang; Jiro Fujita; Michiaki Tokuda; Shuji Bandoh; Toshihiko Ishida
Journal:  Intern Med       Date:  2002-12       Impact factor: 1.271

Review 10.  Respiratory complications in mixed connective tissue disease.

Authors:  U B Prakash
Journal:  Clin Chest Med       Date:  1998-12       Impact factor: 2.878

View more
  1 in total

Review 1.  [Non-infectious granulomatous inflammation: Focus on the lungs and skin].

Authors:  K Holl-Ulrich; C Rose
Journal:  Pathologe       Date:  2016-03       Impact factor: 1.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.